SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001308179-19-000059
Filing Date
2019-03-22
Accepted
2019-03-22 16:20:39
Documents
8
Effectiveness Date
2019-03-22

Document Format Files

Seq Description Document Type Size
1 AMNEAL PHARMACEUTICALS, INC. - DEFA14A lamr2019_defa14a.htm DEFA14A 14972
2 GRAPHIC check.jpg GRAPHIC 1317
3 GRAPHIC lamrxx1x1.jpg GRAPHIC 10598
4 GRAPHIC notice1.jpg GRAPHIC 192213
5 GRAPHIC notice2.jpg GRAPHIC 320206
6 GRAPHIC notice3.jpg GRAPHIC 125316
7 GRAPHIC notice4.jpg GRAPHIC 14335
8 GRAPHIC uncheck.jpg GRAPHIC 1182
  Complete submission text file 0001308179-19-000059.txt   932953
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38485 | Film No.: 19700098
SIC: 2834 Pharmaceutical Preparations